Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grasso

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
Journal of Anesthesia, Analgesia and Critical Care|October 1, 2024
Management of analgosedation during noninvasive respiratory support: an expert Delphi consensus document developed by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)G Spinazzola, S Spadaro, G Ferrone, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2014
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaJoshua I Warrick, Daniel H Hovelson, Anmol Amin, et al.
BMC Cancer|May 9, 2020
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potentialEric T Miller, Sungyong You, Radu M Cadaneanu, et al.
Human Pathology|August 7, 2014
HRAS mutations are frequent in inverted urothelial neoplasmsAndrew S McDaniel, Yali Zhai, Kathleen R Cho, et al.
Nature Medicine|June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
The Journal of Clinical Investigation|April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapyYeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Integrative molecular profiling of routine clinical prostate cancer specimensC S Grasso, A K Cani, D H Hovelson, et al.
Breast Cancer Research and Treatment|September 3, 1999
Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol GroupC Pazos, E Mickiewicz, M R Di Notto, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Journal of Anesthesia, Analgesia and Critical Care|October 1, 2024
Management of analgosedation during noninvasive respiratory support: an expert Delphi consensus document developed by the Italian Society of Anesthesia, Analgesia, Resuscitation and Intensive Care (SIAARTI)G Spinazzola, S Spadaro, G Ferrone, et al.
Virchows Archiv : an International Journal of Pathology|December 16, 2014
Tumor evolution and progression in multifocal and paired non-invasive/invasive urothelial carcinomaJoshua I Warrick, Daniel H Hovelson, Anmol Amin, et al.
BMC Cancer|May 9, 2020
Chromosomal instability in untreated primary prostate cancer as an indicator of metastatic potentialEric T Miller, Sungyong You, Radu M Cadaneanu, et al.
Human Pathology|August 7, 2014
HRAS mutations are frequent in inverted urothelial neoplasmsAndrew S McDaniel, Yali Zhai, Kathleen R Cho, et al.
Nature Medicine|June 8, 2019
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
Nature Medicine|July 4, 2019
Publisher Correction: Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanomaAntoni Ribas, Donald Lawrence, Victoria Atkinson, et al.
The Journal of Clinical Investigation|April 29, 2021
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti-PD-1 therapyYeon Joo Kim, Katherine M Sheu, Jennifer Tsoi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2015
Integrative molecular profiling of routine clinical prostate cancer specimensC S Grasso, A K Cani, D H Hovelson, et al.
Breast Cancer Research and Treatment|September 3, 1999
Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol GroupC Pazos, E Mickiewicz, M R Di Notto, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
Pageof 29